Detalhe da pesquisa
1.
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial.
Lancet Diabetes Endocrinol
; 10(2): 102-111, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953531